. . . . . . . . "Reduces interaction with KDR/VEGFR2. Does not inhibit interaction with MAP3K5." . "104"^^ . . "106"^^ . . "Mutagenesis site occurs in NX_Q5VWQ8-4 at amino acids 104 - 106." . . . . . "neXtProt gold" . . . . . . . . . "2014-09-19T00:00:00.0Z"^^ . . . "neXtProt database" . "CALIPHO project" . . . . . "2" . . .